Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid/CB1 signaling in the mouse periaqueductal gray

[1]  J. Mirnajafi-zadeh,et al.  Microinjection of orexin-A into the rat locus coeruleus nucleus induces analgesia via cannabinoid type-1 receptors , 2015, Brain Research.

[2]  H. Azhdari-Zarmehri,et al.  Orexin-A microinjection into the rostral ventromedial medulla causes antinociception on formalin test , 2014, Pharmacology Biochemistry and Behavior.

[3]  Anoumid Vaziri,et al.  Involvement of orexin-2 receptors in the ventral tegmental area and nucleus accumbens in the antinociception induced by the lateral hypothalamus stimulation in rats , 2013, Peptides.

[4]  S. Sadeghi,et al.  Involvement of orexin-1 receptors in the ventral tegmental area and the nucleus accumbens in antinociception induced by lateral hypothalamus stimulation in rats , 2013, Pharmacology Biochemistry and Behavior.

[5]  H. Azhdari-Zarmehri,et al.  Intra-paragigantocellularis lateralis injection of orexin-A has an antinociceptive effect on hot plate and formalin tests in rat , 2012, Brain Research.

[6]  Masahiko Watanabe,et al.  Behavioral / Systems / Cognitive Activation of Type 5 Metabotropic Glutamate Receptors and Diacylglycerol Lipase-Initiates 2-Arachidonoylglycerol Formation and Endocannabinoid-Mediated Analgesia , 2012 .

[7]  K. Mackie,et al.  Activation of Orexin 1 Receptors in the Periaqueductal Gray of Male Rats Leads to Antinociception via Retrograde Endocannabinoid (2-Arachidonoylglycerol)-Induced Disinhibition , 2011, The Journal of Neuroscience.

[8]  T. Horvath,et al.  Direct inhibition of hypocretin/orexin neurons in the lateral hypothalamus by nociceptin/orphanin FQ blocks stress-induced analgesia in rats , 2011, Neuropharmacology.

[9]  Y. Fathollahi,et al.  Intra-periaqueductal gray matter microinjection of orexin-A decreases formalin-induced nociceptive behaviors in adult male rats. , 2011, The journal of pain : official journal of the American Pain Society.

[10]  Shih-Pin Chen,et al.  Orexins/hypocretins: pain regulation and cellular actions. , 2010, Current pharmaceutical design.

[11]  A. Shekhar,et al.  A KEY ROLE FOR OREXIN IN PANIC ANXIETY , 2009, Nature Medicine.

[12]  K. Lesch,et al.  Altered Sleep Homeostasis after Restraint Stress in 5-HTT Knock-Out Male Mice: A Role for Hypocretins , 2009, The Journal of Neuroscience.

[13]  P. Carrive,et al.  Hypocretin /orexin contributes to the expression of some but not all forms of stress and arousal , 2009, The European journal of neuroscience.

[14]  T. Sakurai,et al.  Orexin/Hypocretin: A Neuropeptide at the Interface of Sleep, Energy Homeostasis, and Reward System , 2009, Pharmacological Reviews.

[15]  A. Yamanaka,et al.  Hypocretin/orexin and nociceptin/orphanin FQ coordinately regulate analgesia in a mouse model of stress-induced analgesia. , 2008, The Journal of clinical investigation.

[16]  D. Hamson,et al.  Neural correlates of arousal‐induced circadian clock resetting: hypocretin/orexin and the intergeniculate leaflet , 2008, The European journal of neuroscience.

[17]  H. Soya,et al.  Inhibitory effects of an orexin-2 receptor antagonist on orexin A- and stress-induced ACTH responses in conscious rats , 2007, Neuroscience Research.

[18]  T. Bisogno,et al.  Elevation of Endocannabinoid Levels in the Ventrolateral Periaqueductal Grey through Inhibition of Fatty Acid Amide Hydrolase Affects Descending Nociceptive Pathways via Both Cannabinoid Receptor Type 1 and Transient Receptor Potential Vanilloid Type-1 Receptors , 2006, Journal of Pharmacology and Experimental Therapeutics.

[19]  J. Crystal,et al.  An endocannabinoid mechanism for stress-induced analgesia , 2005, Nature.

[20]  Kazuhiro Takahashi,et al.  Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and -2) in mice , 2005, Peptides.

[21]  M. Yanagisawa,et al.  Persistent pain and stress activate pain-inhibitory orexin pathways , 2005, Neuroreport.

[22]  J. Longhurst,et al.  Electroacupuncture induces c-Fos expression in the rostral ventrolateral medulla and periaqueductal gray in cats: relation to opioid containing neurons , 2004, Brain Research.

[23]  Y. Ueta,et al.  Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons , 2004, Regulatory Peptides.

[24]  H. Iwaasa,et al.  N-acyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline: the first orexin-2 receptor selective non-peptidic antagonist. , 2003, Bioorganic & medicinal chemistry letters.

[25]  L. Hwang,et al.  Antiallodynic Effects of Intrathecal Orexins in a Rat Model of Postoperative Pain , 2003, Journal of Pharmacology and Experimental Therapeutics.

[26]  T. Sakurai,et al.  Activation of orexin neurones after noxious but not conditioned fear stimuli in rats , 2002, Neuroreport.

[27]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[28]  C. Saper,et al.  Differential expression of orexin receptors 1 and 2 in the rat brain , 2001, The Journal of comparative neurology.

[29]  A. A. Parsons,et al.  Orexin-A, an hypothalamic peptide with analgesic properties , 2001, Pain.

[30]  D Smart,et al.  SB‐334867‐A: the first selective orexin‐1 receptor antagonist , 2001, British journal of pharmacology.

[31]  J. Walker,et al.  Pain modulation by release of the endogenous cannabinoid anandamide. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Pol.  Hypothalamic Hypocretin (Orexin): Robust Innervation of the Spinal Cord , 1999 .

[33]  T. Sakurai,et al.  Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  K. Mackie,et al.  Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system , 1998, Neuroscience.

[35]  A. N. van den Pol,et al.  Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems , 1998, The Journal of Neuroscience.

[36]  S. Carr,et al.  Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.

[37]  F E Bloom,et al.  The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Grandy,et al.  Orphanin FQ acts as a supraspinal, but not a spinal, anti‐opioid peptide , 1996, Neuroreport.

[39]  N. Volkow,et al.  123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. , 1996, European journal of pharmacology.

[40]  M. Ennis,et al.  The effect of GABA and its antagonists on midbrain periaqueductal gray neurons in the rat , 1990, Pain.

[41]  T. Curran,et al.  Expression of c-fos protein in brain: metabolic mapping at the cellular level. , 1988, Science.

[42]  T. Yaksh,et al.  Systematic examination in the rat of brain sites sensitive to the direct application of morphine: Observation of differential effects within the periaqueductal gray , 1976, Brain Research.

[43]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[44]  H. Iwaasa,et al.  Development of an orexin-2 receptor selective agonist, [Ala(11), D-Leu(15)]orexin-B. , 2003, Bioorganic & medicinal chemistry letters.

[45]  M. Eissenstat,et al.  Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor. , 1992, Journal of medicinal chemistry.

[46]  F. Graeff,et al.  Strain-dependent effects of morphine injected into the periaqueductal gray area of mice. , 1991, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[47]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[48]  B. Berkowitz.  The Relationship of Pharmacokinetics to Pharmacological Activity: Morphine, Methadone and Naloxone , 1976, Clinical pharmacokinetics.